The Latest Cardiac and Vascular News
The Mantra Surgical Robotic System has been given the approval to be used for clinical use in Guatemala, marking the Company’s first regulatory approval in Central America FORT LAUDERDALE, FL, Oct. 10, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), […]
GALWAY, Ireland–(BUSINESS WIRE)–WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive initial results from its ongoing DELTA-HF trial evaluating the WhiteSwell eLym™ System. The data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 in […]
SOUTH SAN FRANCISCO, Calif. and CLEVELAND, Oct. 09, 2023 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today released new data for TN-301 at the 2023 Heart […]
NAPERVILLE, Ill., Oct. 9, 2023 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced it has received Investigational Device Exemption (IDE) approval from the FDA for a subsequent multicenter study, PROACTIVE-HF 2, which will evaluate the company’s Cordella Sensor for pulmonary artery […]
SANTA CLARA, Calif., Oct. 8, 2023 /PRNewswire/ — Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced 6-month results of the REBALANCE-HF randomized, blinded feasibility trial of the Splanchnic Ablation for Volume Management (SAVM) procedure for heart failure with preserved ejection fraction (HFpEF). The main objectives of the […]
JUPITER, FL, Oct. 06, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Marizyme, Inc. (OTCQB:MRZM) (“Marizyme” or the “Company”), a global medical technology company focused on the development of products to address unmet clinical needs, today announced that it was granted a de novo from the U.S. Food and Drug Administration (FDA) for its […]
NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–MedAxiom, the cardiovascular community’s premier destination for organizational performance solutions, has developed Peer Review Plus™, the world’s first clinical peer review solution to effectively and efficiently conduct unbiased performance evaluations and case reviews with input from a nationwide network of peers. MedAxiom is currently recruiting healthcare organizations […]
MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical, a developer of innovative cardiovascular technologies, announced it will present primary endpoint and 6-month data from its DESyne BDS Plus Randomized Clinical Trial (RCT), a prospective, multicenter, single-blind study, as part of The Innovation Program at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco. The data […]
HOUSTON, Oct. 5, 2023 /PRNewswire/ — Millar, OEM solutions partner and leader in MEMS pressure sensor integration, is thrilled to announce that it will officially unveil its groundbreaking chronic pressure measurement technology platform, TiSense, at the upcoming MD&M tradeshow in Minneapolis on October 10-11, 2023. This event serves as the perfect stage for Millar to introduce TiSense […]
MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical, a developer of disruptive cardiovascular technologies, announced submission to Japan’s Pharmaceutical and Medical Device Agency (PMDA) for the approval of the DynamX® Coronary Bioadaptor System for the treatment of coronary artery disease (CAD). DynamX coronary bioadaptor was developed to overcome the limitations of drug-eluting stents (DES) and […]
